Prevalence and Predictors of Nonalcoholic Fatty Liver Disease in Family Members of Patients With Nonalcoholic Fatty Liver Disease.
J Clin Exp Hepatol
; 12(2): 362-371, 2022.
Article
em En
| MEDLINE
| ID: mdl-35535086
ALT, Alanine aminotransferase; APRI, AST to platelet ratio index; AST, Aspartate aminotransferase; AUROC, Area under ROC; BMI; BMI, Body mass index; CAP, Controlled attenuation parameter; CI, Confidence interval; EASL, European Association for the Study of the Liver; FAST, FibroScan-AST; FDRs, First-degree relatives; FIB-4, Fibrosis-4; HDL-C, High-density lipoprotein-cholesterol; HbA1C, Glycosylated hemoglobin; LSM, Liver stiffness measure; MetS, Metabolic syndrome; NAFLD, Non-alcoholic fatty liver disease; NASH, Non-alcoholic steatohepatitis; NCEP-ATP, National Cholesterol Education Program- Adult Treatment Panel; NFS, NAFLD fibrosis score; OR, Odds ratio; ROC, Receiver operating curve; family members; nonalcoholic fatty liver disease; predictors
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Guideline
/
Observational_studies
/
Prevalence_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
J Clin Exp Hepatol
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Índia